Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Johnson & Johnson Consumer Inc. Recalls Single Lot of Baby Powder After Tests Reveal Presence of Asbestos
Johnson & Johnson Consumer Inc. announced in a press release that it has voluntarily recalled a single lot of Baby Powder after tests indicated the presence of “sub-trace” levels of chrysotile asbestos.
Missouri Appellate Court Says Talc Ovarian Cancer Appeal Properly Before Court, Reverses $110 Million Verdict
A Missouri appellate court has reversed a $110 million talcum powder ovarian cancer verdict, again finding that the trial court lacked personal jurisdiction over the plaintiffs under the U.S. Supreme Court’s Bristol-Myers Squibb decision.
A plaintiff with talcum powder ovarian cancer claims pending in Florida state court has opposed several motions to dismiss for lack of jurisdiction, maintaining that the defendants bottled talc products for Johnson & Johnson and those products were sold in the state of Florida.
Fla. State Court Denies GSK’s Motion to Dismiss Asbestos Cosmetic Talc Case for Lack of Jurisdiction
A Florida state court has denied GlaxoSmithKline’s efforts to throw out asbestos cosmetic talcum powder claims, rejecting the defendant’s stance that the court did not have personal jurisdiction over the claims.
An asbestos cosmetic talcum powder trial against Johnson & Johnson defendants and Imerys Talc America Inc. is scheduled to begin this month in California, according to recent court documents.
HarrisMartin: California Jurors Reach Defense Verdict in Retrial of Cosmetic Talcum Powder Asbestos Case
Jurors in California have reached a defense verdict for Johnson & Johnson at the conclusion of a retrial in a cosmetic talcum powder asbestos case, HarrisMartin Publishing is reporting.
N.J. Federal Court Tosses Shareholder Suit Against J&J, Says Plaintiff Needs to Seek Pre-Suit Demand
A New Jersey federal court has dismissed without prejudice a shareholder suit accusing Johnson & Johnson of withholding information regarding its talcum powder products, concluding that the New Jersey Business Corporation Act does not support a futility exception to pre-suit demand.
Parties awaiting a Daubert ruling from the federal court overseeing the talcum powder national multidistrict litigation docket have filed summation briefs, with the plaintiffs maintaining that their experts have proffered reliable and qualified opinions linking talcum powder usage to ovarian cancer and defendants countering that the plaintiffs’ experts’ opinions lack general acceptance in the scientific community.
Georgia’s first talcum powder ovarian cancer trial has ended in a mistrial, HarrisMartin Publishing is reporting. Jurors informed the court that they was unable to reach a verdict moments ago after a three-week trial and three days of deliberations.
Issue #34, September 2019
Calif. Jury Awards More than $40 Million at Conclusion of Asbestos Talc Trial; No Punitive Damages Awarded
A California jury has awarded plaintiffs asserting asbestos cosmetic talc claims more than $40 million in compensatory damages at the conclusion of a trial against Johnson & Johnson, sources told HarrisMartin Publishing.